# Spyre Therapeutics, Inc. (SYRE): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/syre for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Spyre Therapeutics, Inc. is a biotechnology firm operating at the preclinical stage, dedicated to creating innovative treatments for individuals afflicted with inflammatory bowel disease (IBD). Among its pipeline candidates is SPY001, a human monoclonal immunoglobulin G1 antibody specifically engineered to target and bind with the a4ß7 integrin. This particular therapy is under development for addressing both ulcerative colitis and Crohn's disease, two forms of IBD. Furthermore, Spyre Therapeutics is advancing SPY002, another human monoclonal antibody that aims to interact with tumor necros...

## Quote & Key Metrics

As of 2026-10-23:

| Metric | Value |
|---|---|
| Price | $90.33 USD |
| Market Cap | $8.34B |
| P/E (TTM) | — |
| EPS (TTM) | −$1.95 |
| 52-Week Range | $21.15 – $110.18 |
| Dividend Yield (TTM) | — |

## Dividend

SYRE has no dividend payment history in our records.

## Frequently Asked Questions

### What does Spyre Therapeutics, Inc. do?

Spyre Therapeutics, Inc. (SYRE) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is SYRE's market cap?

Spyre Therapeutics, Inc. (SYRE) has a market capitalization of approximately $8.34 billion, as of October 23, 2026, based on the most recent share price and shares outstanding.

### Does SYRE pay a dividend?

No, Spyre Therapeutics, Inc. (SYRE) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is SYRE profitable?

Spyre Therapeutics, Inc. (SYRE) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has SYRE ever paid a dividend?

No. Dividend Data's records show no dividend payments from Spyre Therapeutics, Inc. (SYRE). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/syre
- Dividend history & safety: https://www.dividenddata.com/stocks/syre/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/syre/earnings
- Financial statements: https://www.dividenddata.com/stocks/syre/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/syre/valuation
- Peer comparison: https://www.dividenddata.com/stocks/syre/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.